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Mapping Microvasculature 
with acoustic angiography 
Yields Quantifiable Differences 
between healthy and  
Tumor-bearing Tissue Volumes 
in a rodent Model1
Ryan C. Gessner, BS
Stephen R. Aylward, PhD
Paul A. Dayton, PhD
Purpose: To determine if the morphologies of microvessels could be 
extracted from contrast material–enhanced acoustic angio-
graphic ultrasonographic (US) images and used as a quanti-
tative basis for distinguishing healthy from diseased tissue.
Materials and 
Methods:
All studies were institutional animal care and use com-
mittee approved. Three-dimensional contrast-enhanced 
acoustic angiographic images were acquired in both healthy 
(n = 7) and tumor-bearing (n = 10) rats. High-spatial-reso-
lution and high signal-to-noise acquisition was enabled by 
using a prototype dual-frequency US transducer (transmit 
at 4 MHz, receive at 30 MHz). A segmentation algorithm 
was utilized to extract microvessel structure from image 
data, and the distance metric (DM) and the sum of angles 
metric (SOAM), designed to distinguish different types of 
tortuosity, were applied to image data. The vessel popula-
tions extracted from tumor-bearing tissue volumes were 
compared against vessels extracted from tissue volumes in 
the same anatomic location within healthy control animals 
by using the two-sided Student t test.
Results: Metrics of microvascular tortuosity were significantly 
higher in the tumor population. The average DM of the 
tumor population (1.34 6 0.40 [standard deviation]) was 
23.76% higher than that of the control population (1.08 
6 0.08) (P , .0001), while the average SOAM (22.53 6 
7.82) was 50.73% higher than that of the control popu-
lation (14.95 6 4.83) (P , .0001). The DM and SOAM 
metrics for the control and tumor populations were sig-
nificantly different when all vessels were pooled between 
the two animal populations. In addition, each animal in 
the tumor population had significantly different DM and 
SOAM metrics relative to the control population (P , .05 
for all; P value ranges for DM, 3.89 3 1027 to 5.63 3 1023; 
and those for SOAM, 2.42 3 10212 to 1.57 3 1023).
Conclusion: Vascular network quantification by using high-spatial-
resolution acoustic angiographic images is feasible. Data 
suggest that the angiogenic processes associated with tu-
mor development in the models studied result in higher 
instances of vessel tortuosity near the tumor site.
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mentation, have been previously de-
scribed by Kruse and Ferrara (16), 
and the design of the prototype im-
aging transducer has been previously 
presented by Gessner et al (17). The 
purpose of this analysis was to test our 
hypothesis that the morphologies of mi-
crovessels could be extracted from US 
images and used as a quantitative basis 
for distinguishing healthy from diseased 
tissue volumes in a rat model.
Materials and Methods
Animal and Contrast Agent Preparation
All animal protocols used in this pro-
spective study were approved by our in-
stitutional animal care and use commit-
tee. Animals used in this prospective 
study were female Fischer 344 rats (ap-
proximately 250 g, Charles River Labo-
ratories, Durham, NC). A fibrosarcoma 
tumor model was established through 
the implantation of a 1-mm3 sample of 
tissue in the right flank region of the an-
imals as previously described (18). An-
imals were imaged after the tumor had 
grown larger than 0.5 cm in each of the 
three principal axes. The right flanks of 
control (n = 7) and tumor-bearing (n = 
10) animals were imaged. Prior to im-
aging, the area around the right flank 
this approach has been limited by the 
resolution of the low-frequency contrast 
detection approaches used in these 
studies (6–8).
Vessel structural abnormalities are 
known to reveal underlying disease 
very early during the onset of disease 
(9), even after the introduction of only 
tens of cells to an in vivo tissue envi-
ronment (10). Moreover, vessel abnor-
malities have been shown to resolve, or 
normalize, with the administration of a 
successful therapy (11). Thus, analyz-
ing the morphology of a vascular net-
work within a diseased tissue volume 
provides a very sensitive method to 
assess the effects of therapy, which is 
particularly necessary when clinicians 
are seeking to tune their personalized 
therapeutic approaches (12).
Demonstrated herein is a combina-
tion of an algorithm for vessel segmen-
tation, metrics for vessel morphologic 
analysis (13), and a high-spatial-reso-
lution high-contrast imaging approach, 
which together form a system for 
vascular mapping (acoustic angiogra-
phy). Similar vessel segmentation and 
analysis methods have been previously 
implemented for tissue disease and 
tumor response assessment in mag-
netic resonance (MR) angiographic 
data (9,11,14,15). The physics of dual-
frequency contrast-enhanced imaging, 
which enables the acoustic angiographic 
approach essential to microvessel seg- 
U ltrasonography (US) is an attrac-tive medical imaging modality because of its relatively low cost, 
portability, and low level of invasive-
ness. Microbubble contrast agents in 
conjunction with specialized acoustic 
pulsing and receiving schemes have en-
abled the detection of blood flow in mi-
crovessels whose backscattered acous-
tic signal would otherwise be obscured 
in noise. Microbubble contrast agents, 
when introduced into the blood stream, 
can circulate for several minutes before 
being cleared from the system (1).
There are several methods in pre-
clinical and clinical settings to extract 
quantitative data from contrast ma-
terial–enhanced US images to assess 
organ health and disease state. Exam-
ples of these methods include perfu-
sion imaging (2,3) and molecular im-
aging (4,5). Typically, these methods 
attempt to monitor either the amount 
of blood flow within a tissue volume 
(by examining the increase in US sig-
nal from blood pool contrast agents) or 
the presence of molecular markers of 
disease (through imaging of targeted 
contrast agents retained in the tissue), 
respectively. While some groups have 
recently demonstrated the ability to 
quantify the morphology, or architec-
ture, of blood vessels and blood vessel 
networks in thyroid and breast tumors, 
Implications for Patient Care
 n The combination of acoustic angi-
ography with a quantitative mi-
crovascular analysis technique 
can noninvasively provide infor-
mation about the presence of 
microvascular tortuosity abnor-
malities associated with tumor 
presence and growth.
 n This result suggests that US, 
which is low cost, safe, and por-
table, can be used to depict the 
downstream vascular changes 
associated with disease onset 
while tumors are still very small, 
as well as assess tumor response 
to antivascular therapies.
Advances in Knowledge




 n A segmentation algorithm can be 
used to extract microvessel mor-
phology from acoustic angio-
graphic images.
 n A quantitative analysis of 
microvessel morphologies illus-
trates significant differences in 
tortuosity metrics between 
healthy and tumor tissue; av-
erage increase in tortuosity in 
the tumor-bearing population 
over the healthy population was 
23.76% and 50.73%, depending 
on the metric (P , .0001).
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the extracted vessel path and the length 
of the secant line between the vessel’s 
start and end. A vessel’s end points 
are determined by one of several cri-
teria during the automated extraction 
of the vessel’s centerline by the algo-
rithm (ie, the arrival at a bifurcation). 
For an overview of the mechanics of the 
vessel extraction algorithm, the reader 
is referred to Aylward and Bullitt (20). 
The SOAM is an index of vessel tortu-
osity that is computed by integrating 
the angular changes occurring between 
successive pairs of points along the ves-
sel’s centerline, normalized by the to-
tal vessel path length. Occasionally, a 
vessel would exhibit an extremely high 
tortuosity value, several standard devi-
ations away from the mean for the ani-
mal from which it was extracted. These 
values may have been true estimates or 
may have been artifacts from the im-
aging or analysis method. To prevent 
these outliers from grossly skewing the 
distribution of vessel tortuosities, we 
excluded from further analysis any ves-
sel with either a DM or SOAM value 
greater than 3 standard deviations from 
the mean for the animal from which it 
was extracted. As a result of this step, 
between zero and two vessels were re-
moved from each of the 17 animals in 
the study, with an average of 1.06 ves-
sels 6 0.66 (standard deviation) being 
removed per animal. This corresponds 
to an average of less than 4% (number 
of vessels removed from an animal di-
vided by total vessels originally extract-
ed from that animal) of the total vessels 
being removed as outliers from each 
animal (maximum of two vessels, mini-
mum of zero vessels). Additional infor-
mation about the statistics of vascular 
morphologies can be found in Bullitt et 
al (21).
Statistical Analysis
Four types of variability in vessel tor-
tuosity were assessed: interpopulation, 
intrapopulation, interanimal, and intra-
animal. These types of vessel tortuosity 
variability are defined as follows. Inter-
population variability is the differences 
in vessel tortuosity occurring between 
group types (ie, pooled tumor-bearing 
animals vs pooled control animals). 
15-MHz high-pass filter used on the re-
ceived lines of data to further suppress 
tissue signal.
Images were acquired with a frame 
rate of 3 Hz, with a five-frame averaging 
step at each location to suppress spuri-
ous signal from contrast agent flowing 
in vessels smaller than the spatial reso-
lution of the system. Imaging began less 
than 1 minute after the initiation of con-
trast material infusion, and each three-
dimensional acoustic angiographic im-
age required approximately 5 minutes 
to acquire. All three-dimensional im-
ages were acquired with an interimage 
elevational step size of 0.2 mm by us-
ing the linear motion stage of the US 
system. Control tissue volumes in this 
study were defined as the three-dimen-
sional images acquired in non–tumor-
bearing animals, against which the im-
ages acquired in tumor-bearing animals 
were compared. The tissue imaged in 
the control animals was the right flank, 
which was the same location imaged in 
the tumor-bearing population. Both B-
mode and acoustic angiographic images 
were acquired, enabling retrospective 
vascular-tissue overlays and the delin-
eation of tumor boundaries.
Offline Image Analysis
All image data were exported from the 
US system as uncompressed audio-
video interleave files. The images were 
upsampled in the elevational direction 
by using a custom trilinear interpola-
tion script written in Matlab (Math-
Works, Natick, Mass) to yield isotropic 
voxels with a width, length, and height 
of 0.05 mm. This interpolation helped 
expedite the vessel segmentation al-
gorithm. Microvessels were extracted 
from each animal’s image data by using 
the previously described vessel segmen-
tation algorithm based on multiscale 
extraction of centerlines (20). Previ-
ously described vessel morphologic 
metrics (13) were then applied. These 
metrics, which provide a means to as-
sess two distinct types of centerline tor-
tuosity, were the distance metric (DM) 
and sum of angles metric (SOAM). The 
DM is a measure of how far a curve 
meanders between its end points and is 
computed as the ratio of the length of 
was shaved with an electronic clipper. 
A depilating cream was also applied to 
remove the remaining hair in the area. 
A 24-gauge catheter was placed in the 
tail vein for the administration of con-
trast material.
Lipid-encapsulated microbubble 
contrast agents were prepared as pre-
viously described (19), resulting in a 
polydisperse size distribution of con-
trast agents with a mean diameter of 
0.9 µm and concentration of 1 3 1010 
bubbles per milliliter. Prior to intra-
venous administration, microbubbles 
were diluted in saline to a concentra-
tion of 3.3 3 109 bubbles per milliliter. 
Contrast agent was continuously in-
fused through a syringe pump (Harvard 
Apparatus, Holliston, Mass) at a rate of 
70 µL/min.
Image Acquisition
All images were acquired, processed, 
and analyzed by a PhD graduate stu-
dent (R.C.G., with more than 3 years 
of experience working with high-spa-
tial-resolution preclinical US images). 
Volumetric US images were acquired 
with a prototype probe described in 
Gessner et al (17). Briefly, the probe 
is a modification of a commonly used 
high-frequency preclinical transducer 
(RMV 707; VisualSonics, Toronto, On-
tario, Canada) with a 4-MHz element 
added confocally outside of the inner 
30-MHz element. This configuration al-
lows low-frequency excitation of micro-
bubble contrast agents near resonance, 
promoting better contrast sensitivity 
and penetration depth than 30-MHz 
transmit-receive imaging. Furthermore, 
high-frequency harmonics produced by 
the microbubbles are received by the 
high-frequency element and limited 
only by one-way attenuation, pro-
viding substantially better resolution 
than would otherwise be achievable at 
4-MHz transmit-receive imaging. More-
over, the difference between pulsing 
and receiving frequencies enables the 
suppression of tissue signal, because 
echoes from tissue contain substantially 
less high-frequency harmonic content 
than those of microbubbles. The puls-
ing pressure for all images was 1.23 
MPa (mechanical index = 0.62), with a 
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image data of control flanks was 51.51% 
lower (15.86 vessels 6 2.41; range, 13–
19 vessels) than that of the tumor models 
(32.7 vessels 6 9.08; range, 20–50 ves-
sels). The average size of the 10 tumors 
imaged in this study was 11.4 mm 6 3.6 
(range, 5.8–16.8 mm) for the longest 
axis, corresponding to a volume of 0.452 
cm3 6 0.331 (range, 0.070–1.076 cm3). 
Examples of segmented centerlines taken 
from acoustic angiographic image data 
can be seen in Figure 2. The average DM 
for the tumor population was 23.76% 
higher (1.34 6 0.40) than that for the 
control population (1.08 6 0.08) (P , 
.0001) (Fig 3). The average SOAM was 
50.73% higher in the tumor population 
relative to the control population (22.53 
6 7.82 compared with 14.95 6 4.83) (P 
, .0001). The intraanimal variation for 
the DM was 0.07 and 0.33 (control vs 
tumor), which corresponds to a relative 
deviation of 6.60% and 24.90%, respec-
tively. For the SOAM, the average intra-
animal variation was 4.82 and 7.79 (con-
trol vs tumor), which corresponds to a 
relative deviation of 32.10% and 34.53%, 
respectively (Table 1).
The difference between the pooled 
DM ensemble for the tumor-bearing 
population (1.34 6 0.40) and the con-
trol population (1.08 6 0.08) was sig-
nificant (P , .0001) (Fig 3). Similarly, 
the difference between the pooled 
SOAM ensemble for the tumor-bearing 
population (22.53 6 7.82) and the con-
trol population (14.95 6 4.83) was sig-
nificant (P , .0001).
The ensemble of tortuosity values 
computed from the vessels extracted 
from each tumor-bearing animal was 
compared against the pooled control 
population. The P value range for the 20 
tests was 2.42 3 10212 to 5.63 3 1023. Of 
the 20 tumor animal versus control group 
comparisons made, 18 had P values less 
than the Bonferroni-corrected P value of 
.00147. Similarly, the ensemble of tortu-
osity values computed from the vessels 
extracted from each control animal was 
compared against the pooled tumor-
bearing population. The P value range for 
the 14 control animal versus tumor group 
tests was 1.11 3 10216 to 2.09 3 1023. Of 
the 14 tests, 13 had P values less than the 
Bonferroni-corrected P value of .00147. 
were performed: the DM and SOAM 
ensembles from the tumor-bearing 
group versus the control group. The 
second comparison was implemented 
to test interanimal variability in vessel 
tortuosity. The ensemble of tortuosity 
values reported for the vessels extracted 
from each tumor-bearing animal was 
compared against the pooled control 
population to allow us to retrospectively 
simulate a “diagnosis” of these animals 
(ie, an individual patient’s image data 
compared with a healthy control popula-
tion’s data set). Similarly, the ensemble 
of tortuosity values reported for the ves-
sels extracted from each control animal 
was also compared against the vessels 
of the pooled tumor population. For this 
second comparison, a total of 34 tests 
were performed: the DM and SOAM 
ensembles for each of the 17 animals 
compared against the opposite animal 
group’s pool. Finally, a third statistical 
test was used to assess intrapopulation 
variability in vessel tortuosity. The en-
semble of tortuosity values reported for 
the vessels extracted from each animal in 
the study was compared with the pooled 
aggregate of their respective population 
(with their own data removed from the 
pool) to assess the consistency of the 
tortuosity of vessels found within each 
of our two populations. For this third 
comparison, a total of 34 tests were per-
formed: the DM and SOAM ensembles 
for each of the 17 animals compared 
against their own animal group’s pool. 
All three of these statistical tests were 
performed by using Matlab. For the first 
assessment, which tested the differences 
in vessel tortuosity between the vessels 
extracted from the two populations, sta-
tistical significance difference was set at 
P less than .05. In the second and third 
statistical assessments in which multiple 
comparisons were made, a Bonferroni 
correction was implemented and statis-
tical significance difference was set at P 
less than .00147 (original significance 
level .05 divided by the 34 tests).
Results
A total of 438 microvessels were ex-
tracted and analyzed (Fig 1). The aver-
age number of vessels extracted from the 
Intrapopulation variability is the differ-
ences in vessel tortuosities occurring 
within a single population (a single 
tumor-bearing animal vs the pooled 
tumor-bearing population). This is 
computed by taking the standard de-
viation of the average tortuosity values 
for each animal in the population. In-
teranimal variability is the differences 
in vessel tortuosity occurring between 
a single animal and one or more other 
animals of a different animal population 
(a control animal vs the pooled tumor 
population). Finally, intraanimal vari-
ability is the range in tortuosity values 
reported within a single animal (a large 
range suggests a more heterogeneous 
vascular network). The mean intraani-
mal variability is the average intraani-
mal variability across all animals in the 
population. The relative intraanimal 
variability is expressed as a percent-
age and is computed by normalizing an 
animal’s original intraanimal variability 
(ie, standard deviation) with the mean 
tortuosity value, thereby enabling com-
parisons between the variability of two 
different tortuosity metrics.
The statistical significance of the 
differences between the ensembles of 
microvessel segmentations of the two 
animal populations was assessed by us-
ing a two-tailed Student t test. Ensem-
bles are defined as a collection of DM or 
SOAM values; they can consist of these 
tortuosity metrics computed on either 
the vessels extracted from a single an-
imal or the pool of all vessels from the 
animals in a population. When animals 
were compared with their own group, 
equal variances were assumed for the t 
test; although when animals were com-
pared with the opposite group, unequal 
variances were assumed. Three statis-
tical comparisons were made between 
individual animals and their respective 
populations, as well as between the two 
animal populations themselves. The first 
comparison was used to test interpop-
ulation variability in vessel tortuosity. 
All vessel segmentations were pooled 
into two groups, and the reported tor-
tuosity metrics were compared to assess 
gross differences between the healthy 
and tumor-bearing populations. For this 
first comparison, a total of two tests 
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Despite their lack of significance below 
the Bonferroni-corrected P value, there 
were two animals in the tumor animal 
versus tumor group comparisons with P 
values less than .05 compared with only 
one animal in the control animal versus 
control population comparisons with P 
values less than .05 (Table 2). This trend 
could suggest that the degree of intra-
group vessel morphologic heterogeneity 
was slightly greater in the tissue volumes 
containing a highly angiogenic tumor.
Discussion
In this study, we presented a high-spa-
tial-resolution minimally invasive imag-
ing approach and a quantitative analysis 
of microvessel structure extracted from 
these three-dimensional acoustic angio-
graphic images. All tumor-bearing an-
imals had significant increases in both 
of the reported tortuosity metrics (DM 
and SOAM) compared with those of the 
vessels in the control population. The 
results from this study indicated we can 
use microvessel centerlines extracted 
from high-spatial-resolution acous-
tic angiographic images to provide a 
A and C, with the animal’s own popula-
tion pool in Figure 3, B and D.) While 
some of these comparisons resulted in P 
values less than .05, none had P values 
less than the Bonferroni-corrected P 
value of .00147. This suggests that while 
marked differences between control and 
tumor-bearing animal groups were ap-
parent (as per the first and second sta-
tistical assessments), the groups were 
fairly consistent relative to themselves. 
A summary of the P values for these tests 
is listed in Table 2.
Finally, tortuosity ensembles for each 
of the animals were compared against 
the pooled vessel ensemble for their 
respective group to assess intragroup 
heterogeneity. Thirty-four comparisons 
were made: one for each of the two tor-
tuosity metrics in all 17 animals in the 
study. (These tests can be visualized by 
comparing the distributions in Figure 3, 
Figure 1
Figure 1: Maximum intensity projections through three-dimensional acoustic angiographic image data for six animals. Be-
cause these six three-dimensional data sets were projected along the axis of sound propagation, the resulting two-dimensional 
images are oriented in the coronal anatomic plane. The field of view for these images is 2.5 cm in the horizontal (lateral) direc-
tion and approximately 2 cm in the vertical (elevational) direction. Morphologic differences are apparent between the animal 
types both within and outside tumor margins. Dashed lines = approximate tumor boundaries.
Figure 2
Figure 2: Six extracted vessels show how different morphologic features influence the quan-
titative tortuosity metrics. A slowly meandering vessel will have a higher DM, and a vessel with 
high-frequency oscillations will have a higher SOAM.
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between tissue perfusion speed and 
vessel tortuosity remains to be studied 
with our acoustic angiographic imaging 
technique; however, this is of substan-
tial interest because a previous human 
MR study demonstrated that these two 
techniques (vessel morphologic analysis 
and perfusion analysis) provide inde-
pendently useful diagnostic informa-
tion in the assessment of brain tumors 
the same point in the progression of 
the tumor model. Because tumor vol-
ume was not standardized across the 
tumor-bearing animal population, the 
degree to which the heterogeneity be-
tween subjects (tumor volumes, per-
centage of necrosis, growth rates, etc) 
affected the interanimal deviations in 
the reported DM and SOAM values is 
unknown. In addition, the relationship 
quantitative basis for distinguishing 
healthy from diseased tissue volumes. 
The fact that animals within both con-
trol and tumor-bearing populations had 
significant differences from the aggre-
gate pool of their respective groups 
suggests that heterogeneity is present 
within the microvasculature of these 
rodents, although our results also dem-
onstrated there is a greater degree of 
vascular heterogeneity in the presence 
of cancer.
There were several limitations of 
this study. First, the prototype acoustic 
angiographic transducer enables excel-
lent visualization of microvasculature 
but only within a narrow depth of field 
(, 1 cm) centered around the acous-
tic focus (located approximately 1.3 cm 
into tissue). This means that vascula-
ture beneath tumors is rarely captured 
on our images unless the tumors are 
very small, nor are entire tumors vi-
sualized if their diameters in the axial 
direction exceed 1 cm. Further devel-
opments in transducer and US system 
technology would need to be achieved 
before acoustic angiography could be 
implemented clinically with widespread 
utility. Performance of this technique 
is currently in a similar realm of res-
olution and penetration depth as of-
fered by photoacoustic imaging (22). 
While photoacoustic imaging does not 
necessitate a contrast agent to inter-
rogate the microvasculature—an ad-
vantage over our acoustic angiography 
approach—to our knowledge, there are 
not yet systems demonstrated in the 
literature with simultaneous resolution 
and depth of penetration as utilized 
here. Typically, photoacoustic systems 
can achieve either similar spatial reso-
lution at shallower depth of penetration 
(23) or similar depth of penetration 
at a lower resolution (24). Moreover, 
these systems do not possess the por-
tability offered by acoustic angiography, 
and they necessitate computationally 
intensive reconstruction algorithms to 
achieve volumetric imaging.
Another limitation of the study was 
tumor size heterogeneity. While the 
tumors imaged in this study were all 
at least 0.5 cm in diameter, they were 
not all the same size and thus not at 
Figure 3
Figure 3: Box plots show the ensembles of the reported DM and SOAM values for the vessels extracted 
from the right flanks of the two different animal populations—healthy (Controls) and tumor-bearing (Tumors) 
animals. A, C, The ensemble of each animal in the study. B, D, The pooled ensemble for the control and 
tumor-bearing groups.
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Future studies using this quanti-
tative morphologic analysis of vessel 
structure will test the relationship be-
tween vessel tortuosity and other ul-
trasonic methods for assessing disease 
state in genetically engineered animal 
models to compare their relative sen-
sitivities and uniqueness of diagnostic 
information. In addition, the temporal 
sensitivity of the technique will also be 
evaluated, because vascular tortuos-
ity abnormalities have been observed 
when fewer than 100 cancer cells are 
present (10); thus, techniques capable 
of resolving microvasculature are excit-
ing candidate strategies for early can-
cer detection and rapid assessments of 
response to therapy.
Practical applications: An ideal 
bedside clinical imaging modality is 
one which can sensitively, accurately, 
safely, and inexpensively predict ther-
apeutic response, particularly in an era 
when medicine is becoming increas-
ingly personalized. Thus, the capability 
of advanced US imaging and analysis 
techniques may have a substantial role 
in the future of cancer diagnostics and 
assessment. We predict that the tech-
nique for detecting the presence of can-
cer demonstrated in this article, with 
further development, could be used for 
rapid bedside disease assessment in 
several clinical settings.
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(15). Finally, the syngeneic tumor 
grafts utilized here likely will have dif-
ferent microvascular development char-
acteristics than spontaneous tumors. 
Hence, although we have demonstrated 
Table 1












Maximum 1.47 4.45 30.48 53.67
Minimum 1.01 1.01 4.64 7.05
Mean 1.08 1.34 14.95 22.53
Intrapopulation variability 0.08 0.40 4.83 7.82
Intraanimal variability 0.07 0.33 4.82 7.79
Relative intraanimal variability (%) 6.60 24.90 32.10 34.53
Note.—Computations for these quantities are found in the text.
Table 2
Summary of P Values for the Statistical Tests Used to Assess Interanimal  
and Intrapopulation Variability in Vessel Tortuosity
DM SOAM
Group and Animal
Pooled Control  
Population Pooled Tumors
Pooled Control  
Population Pooled Tumors
Control animals
 1 .62 ,.000147*† .75 ,.000147*†
 2 .66 ,.000147*† .47 .0010*
 3 .025 ,.000147*† .41 ,.000147*†
 4 .63 ,.000147*† .19 ,.000147*†
 5 .09 ,.000147*† .18 .002
 6 .61 ,.000147*† .95 ,.000147*†
 7 .09 ,.000147*† .99 ,.000147*†
Tumor-bearing  
 animals
 1 ,.000147*† .89 ,.000147*† .007
 2 .0002* .41 ,.000147*† .79
 3 .0002* .004 ,.000147*† .79
 4 ,.000147*† .91 ,.000147*† .47
 5 .0006* .76 .0016 .28
 6 ,.000147*† .94 ,.000147*† .85
 7 .0005* .81 .0004* .38
 8 .0006* .78 .0002* .046
 9 .0056 .16 .0014* .11
 10 ,.000147*† .14 ,.000147*† .86
Note.—Each cell indicates a comparison between the ensemble of vessel tortuosities for the animal in each row and the pooled 
population in each column.
* P values are less than the Bonferroni-corrected P value of .00147.
† P values more than 10 times smaller than the Bonferroni-corrected P value of .00147.
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